I-Veyong iPase kwakhona uPhicotho lwe-EU EDQM kwakhona

NgoAprili 22, kwafika iindaba ezilungileyo!I-Hebei Veyong Pharmaceutical Co., Ltd. iphinde yafumana isatifikethi se-EU CEPivermectinI-API ekhutshwe yi-Arhente yaseYurophu yoMgangatho waMayeza (EDQM).

IvermectinI-API yenye yeemveliso eziphambili zeVeyong Pharma.Yamkelwa kakuhle ngabathengi ekhaya nakwamanye amazwe ngenxa yokuzinza kwayo okuqinileyo, umgangatho ophezulu kunye nenkqubo yokuvelisa eluhlaza.Ngo-2018, iphumelele isiqinisekiso se-FDA sase-US.

Isatifikethi se-ivermectin CEP sisatifikethi sokuziqhelanisa ne-European Pharmacopoeia, esingaqatshelwanga kuphela kuwo onke amazwe angamalungu e-EU, kodwa samkelwa ngamazwe amaninzi aqaphela isimo se-European Pharmacopoeia.Ukufumana isatifikethi se-CEP kwakhona kukuqatshelwa kweemveliso ze-Veyong Pharma kwimarike yamazwe ngamazwe, ukubonakaliswa kokhuphiswano lwemarike ye-Veyong, kunye nomqondiso obalulekileyo wokuphumeza uphuhliso loshishino olukumgangatho ophezulu kwiimarike zaphesheya.